Drug
Nedaplatin clinical trials
- studies test it
- 27
- open now
- 5
- in phase 3
- 7
- first study started
- 2003
Keep track of what changes. Save the nedaplatin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
27 studies that test it; most in 2011 (3)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 3 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 3 |
| 2018 | 3 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 2
- Phase 2
- 17
- Phase 3
- 7
- Phase 4
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 26
Sun Yat-sen University (6) · Affiliated Cancer Hospital & Institute of Guangzhou Medical University (2) · Zhejiang Cancer Hospital (2) · Chinese Academy of Medical Sciences (2) · Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (2) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University (1) · Yuhong Li (1) · Jiangsu Simcere Pharmaceutical Co., Ltd. (1)
Often tested with
Tested in the same studies.
Paclitaxel (6) · Docetaxel (5) · Endostar protein (2) · Paclitaxel Liposome (2) · Albumin-Bound Paclitaxel (2) · Tegafur (1) · Gimeracil (1) · Oxonic Acid (1)
Studies
Open first, then newest update. How each study uses nedaplatin is read from its arms, and is right about nine times in ten.
Testing it · 27
- Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard TherapyRecruitingPhase 2Zhejiang Cancer HospitalNCT07284836Written as Nedaplatin
- Adebrelimab Combined With Albumin Paclitaxel and Nedaplatin as Neoadjuvant Therapy for Locally Advanced Resectable ESCCNot yet recruitingPhase 2Harbin Medical UniversityNCT06508229Written as Nedaplatin
- Nedaplatin Versus Cisplatin in Treatment for Nasopharyngeal CarcinomaRecruitingPhase 3Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNCT04437329Written as Docetaxel, nedaplatin, fluorouracil
- Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous CarcinomaNot yet recruitingPhase 2Guiyang Medical UniversityNCT05039606Written as Nedaplatin
- Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPCNot yet recruitingPhase 3Sun Yat-sen UniversityNCT03503136Written as nedaplatin
- Postoperative Concurrent Chemoradiotherapy in Treating Patients With High-Risk Salivary Gland CarcinomasCompletedPhase 2Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong UniversityNCT02776163Written as Nedaplatin
- Endostar Combined With Paclitaxel and Nedaplatin in Treating Patients With Recurrent or Metastatic Esophageal CancerCompletedPhase 2Yuhong LiNCT02350517Written as Paclitaxel+Nedaplatin+Endostar
- Nedaplatin in Treatment for Nasopharyngeal CarcinomaCompletedPhase 2Affiliated Cancer Hospital & Institute of Guangzhou Medical UniversityNCT04834206Written as Docetaxel, nedaplatin, fluorouracil
- The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCCStatus unknownPhase 2The First Affiliated Hospital of Zhengzhou UniversityNCT03917966Written as SHR-1210+docetaxel+nedaplatin
- A Prospective Multi-center Phase III Randomized Controlled TrialStatus unknownPhase 3Sun Yat-sen UniversityNCT02607592Written as nedaplatin+pemetrexed
- Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell CarcinomaCompletedPhase 1Sun Yat-sen UniversityNCT02964455Written as Nedaplatin
- SHR-1210 in Combination With Apatinib and Chemotherapy in Patients With Advanced Esophageal Squamous Cell CancerStatus unknownPhase 2Chinese Academy of Medical SciencesNCT03603756Written as Nedaplatin
- Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase Ⅱ Clinical TrailTerminatedPhase 2Sun Yat-sen UniversityNCT02789189Written as nedaplatin and gemcitabine
- Endostatin Combined With Chemotherapy for Adjuvant Treatment of Esophageal CancerStatus unknownPhase 2First Affiliated Hospital of Guangxi Medical UniversityNCT03649945Written as Nedaplatin
- Nedaplatin (Jiebaishu®) Combined With Docetaxel for Advanced Lung Squamous Cell CarcinomaCompletedPhase 4Jiangsu Simcere Pharmaceutical Co., Ltd.NCT02088515Written as Nedaplatin
- Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal CarcinomaCompletedPhase 3Sun Yat-sen UniversityNCT01540136Written as Nedaplatin
- Liposomal Paclitaxel Combined Nedaplatin in Treatment of Advanced or Recurrent Esophageal CarcinomaCompletedPhase 2Sun Yat-sen UniversityNCT02861690Written as Nedaplatin
- Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical CancerStatus unknownPhase 2Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityNCT02835404Written as Nedaplatin
- Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung CancerStatus unknownPhase 3Guangdong Association of Clinical TrialsNCT02643407Written as Nedaplatin
- NPC Staged N2-3M0:Adjuvant Chemotherapy or Just Observation After Concurrent ChemoradiationTerminatedPhase 2Jiangsu Cancer Institute & HospitalNCT01694576Written as Adjuvant chemotherapy with paclitaxel and nedaplatin
See all 27 studies that test nedaplatin →
Given in every arm · 11 — nedaplatin is usual care beside what is tested
- Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or SurgeryNot yet recruitingPhase 2Fujian Cancer HospitalNCT07046221Written as Nedaplatin
- Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous CarcinomaNot yet recruitingPhase 2The First Affiliated Hospital of Xiamen UniversityNCT07019181Written as Nedaplatin
- Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell CarcinomaRecruitingPhase 2Fuzhou General HospitalNCT05515315Written as Nedaplatin
- Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell CarcinomaRecruitingPhase 2Cancer Institute and Hospital, Chinese Academy of Medical SciencesNCT06170697Written as Nedaplatin
- Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of Local Advanced (LA) HNSCCRecruitingPhase 3Beijing Tongren HospitalNCT06102395Written as Nedaplatin
- Toripalimab Plus Neoadjuvant Chemotherapy Combined With Chemoradiotherapy for Locally Advanced Unresectable Esophageal Squamous Cell CarcinomaActive, not recruitingPhase 2Sun Yat-sen UniversityNCT04844385Written as Nedaplatin
- Neoadjuvant Therapy of PD-1 Blockade Combined With Chemotherapy for Esophageal CarcinomaStatus unknownPhase 1/2Beijing Friendship HospitalNCT05777707Written as Carboplatin/Nedaplatin
- A Phase II Clinical Trial of Chemotherapy With or Without Endostar® Continuous Intravenous Infusion in Refractory NPCStatus unknownPhase 2Yun-fei XiaNCT02590133Written as Nedaplatin
- Simultaneous Integrated Boost Radiotherapy and Concurrent Chemotherapy for Locally Advanced Esophageal CarcinomaCompletedPhase 1/2Chinese Academy of Medical SciencesNCT02429622Written as Nedaplatin
- The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal CarcinomaStatus unknownPhase 3Changjie HuangNCT02537925Written as Nedaplatin
- Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC)CompletedPhase 1/2Jiangsu Cancer Institute & HospitalNCT01712919Written as Concurrent chemotherapy with paclitaxel and nedaplatin
As the comparator · 1 — what is tested is compared with nedaplatin
Codes
What other systems call nedaplatin · ClinicalTrials.gg INT003352
- MeSH (NLM) C053989nedaplatinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 8UQ3W6JXANNEDAPLATINConfirmed FDA, NLM, Wikidata
- Wikidata Q6986146nedaplatinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61099NedaplatinOne source FDA
- DrugBank DB13145One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C053989 | nedaplatin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 8UQ3W6JXAN | NEDAPLATIN | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q6986146 | nedaplatin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61099 | Nedaplatin | One source FDA |
| DrugBank | DB13145 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.